EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $7,889,000 | -80.0% | 100,000 | -79.9% | 0.40% | -85.9% |
Q4 2016 | $39,527,000 | +1317466.7% | 498,198 | -8.5% | 2.81% | – |
Q3 2016 | $3,000 | -100.0% | 544,770 | +81.6% | 0.00% | -100.0% |
Q2 2016 | $11,637,000 | +53.5% | 300,000 | +60.2% | 0.81% | +21.4% |
Q1 2016 | $7,582,000 | -35.8% | 187,215 | +40.6% | 0.66% | -23.8% |
Q4 2015 | $11,806,000 | -35.2% | 133,145 | -45.9% | 0.87% | +19.9% |
Q3 2015 | $18,218,000 | -3.3% | 246,088 | +5.6% | 0.73% | -35.9% |
Q2 2015 | $18,844,000 | +3624.1% | 233,044 | +1827.9% | 1.14% | +2810.3% |
Q1 2015 | $506,000 | – | 12,088 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 4,780,188 | $353,877,000 | 83.76% |
JW Asset Management, LLC | 848,709 | $62,830,000 | 22.76% |
Consonance Capital Management LP | 1,353,913 | $100,230,000 | 14.10% |
Cormorant Asset Management, LP | 300,000 | $22,209,000 | 3.55% |
Park West Asset Management LLC | 500,591 | $37,059,000 | 3.38% |
Opaleye Management Inc. | 73,200 | $5,419,000 | 2.67% |
Ranger Investment Management | 428,295 | $31,707,000 | 1.79% |
WALL STREET ASSOCIATES | 119,900 | $8,876,000 | 1.70% |
Timpani Capital Management LLC | 27,090 | $2,005,000 | 0.81% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 22,375 | $1,656,000 | 0.79% |